Market Data
GAO Finds Cannabis Banking’s Gap: An Account Doesn’t Mean Full Access
Federal investigators heard from 74 financial institutions and 51 cannabis businesses. Their report describes costly accounts, restricted credit and fragile payment services, while warning that its roughly 1,000 reporting institutions are not a directory of banks accepting dispensaries.
Florida’s Cannabis Renewal Bill Is $1.34 Million. Fino Has One Store
Florida lists 941,509 active cardholders and 779 dispensaries, even as Parallel closes growing facilities. For new entrant Fino, an August marketing proposal adds another constraint: how to reach patients while carrying the cost of a vertically integrated business.
Connecticut Collected 67% More Cannabis Tax on Flat Sales. The Math Behind It Dies Oct. 1
The state's per-milligram THC tax kept climbing as shelf prices fell 40%, pushing effective rates to 35% on some products. A flat 10.75% excise replaces it Oct. 1, at a projected cost to the state of $1.9 million a year, and operators like Fine Fettle's Ben Zachs say it can't come soon enough.
Curaleaf Goes Hostile for Aurora Cannabis at $4 a Share. Aurora Says the Terms Were Never Fully Spelled Out.
Boris Jordan's June 23 letter named no price and his July 7 letter no cash-stock split, Aurora says. Now a $272 million offer with a $5 cap heads for a special committee, a 105-day clock and a TD Cowen note calling it too low.
Delaware Predicted $281 Million in Weed Sales. Year One Came In at $53 Million.
The state's first marijuana commissioner, a retired state police superintendent, forecast a $281 million market. His successor inherited one-fifth of it, and a border where the same edibles sell for half price in Maryland.
Five Years and Three Failed License Rounds Later, Alabama Finally Sold Its First Legal Cannabis
Amanda Taylor's June purchase at Callie's Apothecary in Montgomery ended the slowest medical launch in US history, 102 patients followed in week one. Eleven more dispensaries are promised, and the licenses that decide the market's real size just went to trial in Tuscaloosa.
Washington's Cannabis Market Shrinks a Fourth Straight Year Under a 37% Excise Tax
The pioneer market sold $1.14 billion in 2025, down about 22 percent from its peak. A state audit estimated growers produced two to three times licensed retail sales in 2023. Earlier tax-increase proposals sharpened the policy debate, but the 2026 legislative session ended in March.
Cannabist Reached US Bankruptcy Protection Through a Canadian Side Door
Cannabis companies have long faced barriers in federal bankruptcy court. On May 9, Judge Brendan Shannon recognized The Cannabist Company's Canadian insolvency without a written opinion, giving a company with about $220 million in funded debt a Chapter 15 route to protection.
Glass House Went 'Medical-Only' to Reach the NYSE, and Kept 90% of Its Stores' Profits
The $2.5 million deal that moved California's largest grower off its own dispensaries follows Trulieve's three-week-old playbook. But Kyle Kazan's real target isn't the opening bell, it's the export and interstate-commerce market that rescheduling just cracked open.
Curaleaf Prints $70M as Green Thumb Rides Minnesota and Trulieve's Revenue Slips 4%
Three of the largest MSOs reported the first quarter under federal medical-cannabis rescheduling, and the prints split: Curaleaf's $70.1 million GAAP net income looks like a normal company's, while Trulieve's revenue still slipped 4% year-over-year. Analysts now watch the June 29 DEA hearing, and whether the divergence holds.
280E Relief Lands: Trulieve Posts $287M Q1 Revenue and a 35% EBITDA Margin
The first quarter of post-rescheduling P&L visibility is here. Trulieve's medical-heavy revenue mix turns the Section 280E disallowance from a 70%-effective tax rate into a normal one. The market is repricing.